Kwaku Marfo

ORCID, self-asserted

ORCID 0009-0003-5922-0956

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

10 works in the graph, newest first.

Systematic literature review on hydroxyurea treatment of SCD in low- to middle-income countries
2026Journal of sickle cell disease.JournalOpen access0 citations10.1093/jscdis/yoag018
Effectiveness of hydroxyurea (hydroxycarbamide) in a national sickle cell disease programme in Ghana
2025British Journal of HaematologyJournalOpen access2 citations10.1111/bjh.70079
Th role of counselling to reduce parental fears and anxiety about newborn screening for sickle cell disease in Northern Ghana
2025BMC Public HealthJournalOpen access1 citations10.1186/s12889-025-24134-9
Safety profile of crizanlizumab 5.0 mg/kg in sickle cell disease: pooled data from clinical trials
2025Journal of sickle cell disease.JournalOpen access0 citations10.1093/jscdis/yoaf036
Barriers and facilitators to community acceptability of integrating point-of-care testing to screen for sickle cell disease in children in primary healthcare settings in rural Upper East Region of Northern Ghana
2024PLoS ONEJournalOpen access8 citations10.1371/journal.pone.0303520
Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
2023Annals of Global HealthJournalOpen accessCorresponding20 citations10.5334/aogh.4132
Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
2023BMC Health Services ResearchJournalOpen accessFirst author8 citations10.1186/s12913-023-09984-6
P1489: MANAGEMENT OF SICKLE CELL DISEASE WITH HYDROXYUREA: A SYSTEMATIC REVIEW FROM LOW- AND MIDDLE-INCOME COUNTRIES
2022HemaSphereJournalOpen access0 citations10.1097/01.hs9.0000848812.59349.97
P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY
2022HemaSphereJournalOpen access0 citations10.1097/01.hs9.0000872916.50939.2e
P-007: HYDROXYUREA FOR THE MANAGEMENT OF SICKLE CELL DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW (2000–2022)
2022HemaSphereJournalOpen access0 citations10.1097/01.hs9.0000872932.23177.e8